Why? Not obviously in any guidelines and the staging systems do not include either assessment of stage nor grade based on CT findings nor assessment of response. 1
'Well it allows us to separate those who we will be sending for autograft and those who we will not be.
'Started as a chest to make sure there is nothing lurking due to the immunosuppression and dangers from the induction chemo'
So, seems like a 'wunscherfullung' expansion into the 'global prognostics' domain.
Will demonstrate other pathologies which can lead to confusion, delay and potential mis or delayed treatment. ( Case with confusion over lytic lesions ?? myeloma needing WBMRI after a CT body )
Nil that I can find about role of CT.
Nil in the BSH about this. Only AML in pregnancy. 2
NCCN 3 says use it for - ? Extramedullary disease (rare) = use PET-CT. - Neuro dis & complications = Use MR with Gd or CT for haem.
Nil that I can find demonstrating CT effective in classifying patients.
Footnotes
-
DynaMed [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. T114798, Acute Myeloid Leukemia (AML); [updated 2018 Dec 04, cited 3/8/20]. Available from https://www.dynamed.com/topics/dmp~AN~T114798 ↩
-
https://b-s-h.org.uk/guidelines/guidelines/?search=acute+myeloid+leukaemia ↩
-
https://jnccn.org/view/journals/jnccn/15/7/article-p926.xml ↩